ATAI Life Sciences N.V. (ATAI) financial statements (2022 and earlier)

Company profile

Business Address 180 VARICK STREET
NEW YORK, NY 10014
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments362,266430,308453,622
Cash and cash equivalents362,266430,308453,622
Receivables913  
Prepaid expense7,7136,915416
Other current assets756461111
Other undisclosed current assets3,4344,1753,437
Total current assets:375,082441,859457,586
Noncurrent Assets
Property, plant and equipment149138331
Long-term investments and receivables31,59434,03440,469
Long-term investments27,75929,34235,887
Accounts and financing receivable, after allowance for credit loss 9081,388
Due from related parties3,8353,7843,194
Other noncurrent assets7,3411,262689
Other undisclosed noncurrent assets 6,8166,886
Total noncurrent assets:39,08442,25048,375
TOTAL ASSETS:414,166484,109505,961
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities20,83315,04914,026
Accounts payable6,0041,9746,202
Accrued liabilities14,82913,0757,824
Deferred revenue 180120
Debt 3839
Business combination, contingent consideration, liability5150 
Other liabilities51  
Total current liabilities:20,93515,31714,185
Noncurrent Liabilities
Long-term debt and lease obligation7438001,176
Long-term debt, excluding current maturities7438001,176
Liabilities, other than long-term debt6,5295,2325,705
Other liabilities4,0973,2853,239
Business combination, contingent consideration, liability2,4321,9472,466
Total noncurrent liabilities:7,2726,0326,881
Total liabilities:28,20721,34921,066
Stockholders' equity
Stockholders' equity attributable to parent376,908453,186474,850
Common stock18,00217,87017,299
Additional paid in capital725,045709,475691,382
Accumulated other comprehensive income (loss)(8,336)(5,233)3,937
Accumulated deficit(357,803)(268,926)(237,768)
Stockholders' equity attributable to noncontrolling interest9,0519,57410,045
Total stockholders' equity:385,959462,760484,895
TOTAL LIABILITIES AND EQUITY:414,166484,109505,961

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
Revenues230266 
Gross profit:230266 
Operating expenses(45,405)(33,627)(61,319)
Operating loss:(45,175)(33,361)(61,319)
Nonoperating income (expense)(3,404)6,887(5,982)
Foreign currency transaction gain, before tax3,0356,462 
Other nonoperating income (expense)62(29)(2,676)
Loss from continuing operations before equity method investments, income taxes:(48,579)(26,474)(67,301)
Loss from equity method investments(49,115)(4,800)(2,937)
Other undisclosed income from continuing operations before income taxes58,555  
Loss from continuing operations before income taxes:(39,139)(31,274)(70,238)
Income tax expense (benefit)4,421(368)(58)
Loss before gain (loss) on sale of properties:(34,718)(31,642)(70,296)
Other undisclosed net income (loss)(58,555) 16,923
Net loss:(93,273)(31,642)(53,373)
Net income attributable to noncontrolling interest4,3964844,912
Net loss available to common stockholders, diluted:(88,877)(31,158)(48,461)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
Net loss:(93,273)(31,642)(53,373)
Other undisclosed comprehensive income (loss)(3,081)(9,158)2,110
Comprehensive loss:(96,354)(40,800)(51,263)
Comprehensive income, net of tax, attributable to noncontrolling interest4,3984724,762
Comprehensive loss, net of tax, attributable to parent:(91,956)(40,328)(46,501)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: